Coverage
-
November 14, 2017
The U.S. Department of Justice told a California federal court Monday not to award a whistleblower $78 million of a $280 million settlement for her work in prosecuting a False Claims Act suit against Celgene Corp. over the alleged promotion of off-label uses for two cancer drugs, saying $65 million is enough.
12 other articles on this case.
View all »